chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My first 24 hours included sore arm, feeling hot with no fever, joint pain, and achiness. On 3/31/21, I began to experience extreme heartburn almost to the point of vomiting. I had a very sensitive stomach/reaction to food until Saturday 4/3/21.  I was not able to eat a lot and felt generally unwell. In addition, my menstrual cycle began Sunday 4/25/21 when it was not set to begin until Tuesday 4/27/21, I have not yet seen if it's heavier than normal.
After 5 minutes of receiving the COVID-19 Vaccination J&J/Janssen, the patient began to feel warm and experience hot flashes. She reported brief hearing loss and numbness throughout her body. 911 was called and they arrived 6 minutes later. Her blood pressure and pulse was taken and she was taken to the hospital on a stretcher.
Symptoms started on day 8 after vaccination. These included:fever of 99.9 progressing to 100.7 within two days, swollen lymph nodes left axiliary, hot, red, swollen area approx. 5" in diameter accross vaccination site. Went in to see physician on March 8th. Dr. diagnosed as celluitis to the arm and placed patient on antibiotic Keflex. Information was obtained from patient on follow-up call from Vaccine Diary on 4-17-2003.
This spontaneous report as received from a registered nurse concerning to unspecified number of patients of unknown age or gender. No concurrent condition, medical history or allergy/drug reactions were reported. On an unknown date, the patients' were vaccinated with improperly stored doses of PROQUAD (lot # L019996, expiration date: 02-DEC-2016, lot # L007230, expiration date: 03-SEP-2016, and lot #K011312, expiration date: 14-FEB-2016), (dose, route and anatomical location were unspecified). No concomitant medications were reported. No adverse symptoms were reported. Additional information has been requested.
There was no adverse event at the time of this report.   (LVN) administered a booster dose (0.25ml) to pt  who was 16 years old at the date of vaccination. However,  the Moderna covid 19 vaccine is only indicated in 18 or older. Without my knowledge, the nurse verified the patient's information and gave the vaccine
Headache, no appetite, short of breath, bloating in belly, unable to lie down without being short of breath this was new, so went to ER.
pt recv vax 23JAN97 & 28JAN97 in the morning the pt devel 12 lesions, & devel 30 lesions by the afternoon/evening;by 29JAN97 pt had devel more than 50 lesions on neck, & body was covered w/lesions;sx described as full blown chickenpox;
quit taking the flu shot, it started making me sick; Initial information received on 19-Oct-2023 regarding an unsolicited valid social media non-serious case received from patient.  This case involves an unknown age and gender patient who quit taking the Influenza Vaccine shot, as it started making patient sick.  The patient's past medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date, the patient received unknown dose of suspect influenza vaccine produced by unknown manufacturer (strength, form, batch number and expiry date unknown) via unknown route in unknown administration site for prophylactic vaccination (immunization).  On an unknown date the patient had quit taking the flu shot, it started making sick (illness) (unknown latency) following the administration of influenza vaccine.  It is unknown if there were lab data/results available.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (quit taking the flu shot, it started making me sick).  At time of reporting, the outcome was Unknown for the event quit taking the flu shot, it started making me sick.
patient came into store and stated he is a handy man and his arm hasn't stopped hurting since his flu shot friday, that it is very painful so much so that he cannot do his work.
Slight dizziness within 1 hour of injection; Lethargy; This is a spontaneous report from a contactable consumer (patient). A 64-Year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and expiration date were unknown), via an unspecified route of administration on 17Feb2021 at 11:15 (at the age of 64-years-old) via unspecified route as a single dose in left arm for COVID-19 immunisation at workplace clinic. The patient's medical history included Urothelial carcinoma. The patient had no known allergies. Concomitant medications in two weeks were atenolol, Ascorbic Acid (VIT C), Ergocalciferol (VIT D). The patient did not receive any other vaccines within four weeks prior to the vaccination. Patient received first dose (historical vaccine) of BNT162B2 (Lot Number: Unknown) on 21Jan2021, at 10:00 AM, in left arm, facility type for dose 1 was workplace clinic. On 17Feb2021 at 13:00, the patient experienced slight dizziness within 1 hour of injection and lethargy 10 hours after vaccine. Patient received no treatment for the adverse events. Patient received second vaccine on 17Feb2021, submitted report on 18Feb2021 and adverse events occurred on 17Feb2021. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The clinical outcome of the events was recovering. Information on the lot/batch number has been requested.
This case was reported by a consumer via call center representative and described the occurrence of ringing in ears in a 55-year-old male patient who received SHINGRIX for prophylaxis. On 27th December 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 8th March 2019, the dose was an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced ringing in ears. On an unknown date, the outcome of the ringing in ears was not recovered/not resolved. It was unknown if the reporter considered the ringing in ears to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the left arm. The patient could not recall when the event began but believed it was at least 6 weeks ago. Did not consent to follow up. The patient did not want to provide his physician contact information.
Pt recvd 3 Engerix-B vax given 6SEP89, 13OCT89, & 5MAR90; following these titer was neg; Pt was given a 4th dose of vax on 8AUG90; following 4th dose titer was neg;
developed increased weakness, mild shortness of breath with activity, cough and poor appetite.  Hospitalized 11/16/21-11/20/21
pt devel a fever of 102;no further details known as of the date of this report;this is one of three patients from this site who exp above rxn
Sore arm for about three days.   Fatigue for one day.   Slight nausea for one day.
started w/sore throat, dizziness, sinus blocked-breathing wheezy-went to MD bronchitis cold;
Immediate, intense pain in shoulder. Continued pain, swelling, range of motion loss, weakness in shoulder and arm. Swelling on top of left wrist. When wrist is flexed, pain / shock feeling in palm of left hand.
11/30 T 101 Dr. ran rapid strep -> negative continue to have ear and sinus trouble. 12/18 Dr. irrigated (L) ear (perforated) & did sinus x-rays.
Waited for the 15 minute observation period and felt fine, but while driving home (approximately 20 minutes after injection) I caught a glimpse of my face in the rearview mirror and noticed that it was swollen, specifically in the cheeks and under eye regions. When I got home 5 minutes later, it was more swollen and my throat was feeling tight, though not obstructing my breathing. I monitored the reaction and did not take any medications. About 30 minutes after the reaction began (50 minutes after injection), the facial swelling began to diminish and both the facial swelling and throat swelling went away within about an hour from the onset of the reaction, I was very tired and had a headache the rest of the day, which I understood to be more typical symptoms.
tingling on the left arm; numbness on the left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PARAESTHESIA (tingling on the left arm) and VACCINATION SITE HYPOAESTHESIA (numbness on the left arm) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0132204 or 01322021) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PARAESTHESIA (tingling on the left arm) and VACCINATION SITE HYPOAESTHESIA (numbness on the left arm). At the time of the report, VACCINATION SITE PARAESTHESIA (tingling on the left arm) and VACCINATION SITE HYPOAESTHESIA (numbness on the left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Inj given 9:30 AM (9/11/07) - 3rd inj. Temp 99.3 - abd pn, diarrhea (2:30 pm)
Information was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, drug reactions and allergies were not reported. On 27-JUL-2018, the patient was vaccinated with properly stored but expired PROQUAD for prophylaxis (lot number N002916 and expiration date 24-JUL-2018) (expired product administered) (dose, frequency, route of administration and anatomical location were not reported). No adverse effects were reported. Upon receipt of follow-up information it was determined that this case is now valid because the patient identifier was received. Follow-up information was received from nurse on 08-AUG-2018. This report refers to 5-year-old female patient. Other suspect therapies included KINRIX.
On 02/12 pt was not able to swallow anything no drink or food. Was only able to breathe. He was in country @ the moment. He had to come back to country and admitted to hosp. lost 25 lbs. and got 5 plasma transfusions. He was just released from hospital.
Patient had 3 doses of Moderna COVID vaccine on 1/10/22, 5/12/21, and 4/14/21, and was hospitalized with COVID resp failure on 1/18/22
Information has been received on 06-JUN-2018 regarding a case in litigation from a lawyer and a male consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 15-AUG-2012, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. During 2015, the patient was treated by a physician at an internal medicine office for a persistent and severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient has suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Shaking; Diarrhea; Fever; Vomiting; Weakness; A spontaneous report was received from a consumer concerning 84 years old male patient developed shaking/tremor, diarrhoea, fever/pyrexia, vomiting.   The patient's medical history was not provided.  Products known to have been used by the patient, within two weeks prior to the event, included Insulin.   The patients received their unknown of two planned doses of mRNA-1273 (Batch number: 029L20A) on 22 Jan 2021 intramuscularly in the unknown injection site for prophylaxis of COVID-19 infection.   On 22 Jan 2021 the patient experienced side effects for a two-hour time between 2:30 and 4:30 he experienced shaking, diarrhea, fever, vomiting, and weakness. Treatment for the event was not provided.  Action taken with mRNA-1273 in response to the event(s) was not provided/unknown.  The events shaking, diarrhoea, fever, and vomiting was considered resolved on 22 Jan 2021.
ED to Hosp-Admission Discharged  3/8/2021 - 3/9/2021 (14 hours) Hospital MD Last attending ? Treatment team Dementia without behavioral disturbance (CMS/HCC) Principal problem Discharge Summary MD (Physician) ? ? Internal Medicine    Inpatient Discharge Summary   BRIEF OVERVIEW Admitting Provider: MD Discharge Provider: MD Primary Care Physician at Discharge: CRNP    Admission Date: 3/8/2021     Discharge Date: 3/27/2021   Discharge Diagnosis  Hospital Problems          POA   * (Principal) Dementia without behavioral disturbance (CMS/HCC) Yes       Aortic stenosis Yes       Atrial fibrillation (CMS/HCC) Yes       Chronic obstructive pulmonary disease (CMS/HCC) Yes       Congestive heart failure (CMS/HCC) Yes       Coronary artery disease with history of myocardial infarction without history of CABG Not Applicable       Depression Yes       History of aortic valve replacement Not Applicable       Hyperlipidemia Yes       Hypertension Yes       Peripheral vascular disease (CMS/HCC) Yes       Ambulatory dysfunction Yes       Dementia (CMS/HCC) Yes       CKD (chronic kidney disease) Yes       History of TIA (transient ischemic attack) Not Applicable       Dementia with behavioral disturbance (CMS/HCC) Unknown             DETAILS OF HOSPITAL STAY   Presenting Problem/History of Present Illness/Reason for Admission AKI (acute kidney injury) (CMS/HCC) [N17.9] Dementia with behavioral disturbance (CMS/HCC) [F03.91] Generalized weakness [R53.1] Patient is an 87 y.o. male with past medical history of hypertension, hyperlipidemia AFib not on anticoagulation, sick sinus syndrome status post pacemaker, aortic stenosis status post valve replacement.Coronary artery disease status post CABG, CHF, history of peripheral vascular disease, history of carotid stenosis, severe vertebral artery stenosis, diabetes, CKD, dementia, chronic respiratory failure on 2 L nasal cannula post COVID-19 pneumonia 11/2020 was brought to the emergency room by the family due to worsening confusion and agitation, as per wife after the patient was discharged back in November in few weeks patient dementia started to get worse, more confused, more agitated and few times he was violent to his family members, well for the last few days patient's wife reported that his confusion was very bad so she decided to bring him to the ED for further evaluation management.     Hospital Course -For the above presentation patient was admitted to the hospital services, patient was started on oxygen supplementation, Covid repeat test continue to be positive, started on IV antibiotics, IV hydration due to worsening kidney function, in the evening of 3/8 patient was found without any spontaneous respiration, patient was pronounced dead by the RN and CRNP finished the discharge defecate, please refer to RN documentation for more details.
This case was reported by a nurse via sales rep and described the occurrence of pain in a 59-year-old female patient who received SHINGRIX. Co-suspect products included SHINGRIX. The patient's past medical history included shingles (in early 50's around the time that the patient was going through menopause). On an unknown date, the patient received the 1st dose of SHINGRIX and the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced pain, muscle pain, cramp and activities of daily living impaired. On an unknown date, the outcome of the pain, muscle pain, cramp and activities of daily living impaired were unknown. It was unknown if the reporter considered the pain to be related to SHINGRIX. It was unknown if the reporter considered the muscle pain, cramp and activities of daily living impaired to be related to SHINGRIX. Additional details were provided as follows: The reporter reported that the reporter's mother shared with her that her sister had received SHINGRIX. On an unknown date, less than a year after receiving 1st dose of SHINGRIX, the patient experienced mild pain. On an unknown date, less than a year after receiving 2nd dose of SHINGRIX, the patient experienced lots of muscle aches and cramps which caused her to stay in bed and interrupted her activities of daily living. The reporter did not know if there had been resolution and stated that her mother informed her of her sister's experience approximately 1.5 weeks ago.
Shingles; Shingrix vaccine 2 plus ago with no booster/ It was an oversight on my physicians part.; This case was reported by a consumer via call center representative and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles and incomplete course of vaccination. On an unknown date, the outcome of the shingles and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported, however the age group captured as Adult as per vaccine indication. The patient received 1st dose of Shingrix more than 2 years prior to the reporting. After that patient did not received 2nd dose due to physician's oversight which led to incomplete course of vaccination. After 1st dose, in March, the patient developed shingles. At the time of report, the patient enquiring that if they need to restart the schedule. The reporter declined consent for follow up.
Patient began experiencing severe limb pain for about 6-8 weeks which was accompanied by weakness which continued to develop over the next few months. Once the pain disappeared, she was left with nerve damage and extreme weakness. She was diagnosed with either Guillain Barre Syndrome or it's more severe counterpart of CIDP. She underwent a spinal tap and multiple 8 hour IVIG treatments at the hospital. She is still currently undergoing neurology appointments, physical therapy and continued treatment. Symptoms originally started about 2 weeks after the vaccine and have continued over the last 6 months.
Pt was given 1/2 dose or booster instead of 2nd dose.  We noticed within 10 minutes of vaccinating patient and called him in for the other half
Cried inconsolably for hours after 4:30 none of her usual tricks worked.
Information has been received on 26-FEB-2019 regarding a case in litigation from a lawyer concerning a male patient of unknown age. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. In or around 26-OCT-2016, the patient was inoculated with the ZOSTAVAX (lot number, expiration, dose and route unknown) for routine health maintenance and for its intended purpose: the prevention of shingles. Shortly after receiving ZOSTAVAX, the patient suffered from deteriorated visual impairment, retinal edema, and posterior vitreous detachment. As a direct and proximate result of ZOSTAVAX, the patient's symptoms have resulted in physical limitation not present prior to using ZOSTAVAX. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of the patient's condition. As a result of ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of ZOSTAVAX, the patient suffered serious, progressive, permanent and incurable injuries, as well as conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of ZOSTAVAX, the patient has suffered and incurred damages, including medical expenses, loss of accumulations and other economic and non-economic damages. Deteriorated visual impairment, retinal edema and posterior vitreous detachment were considered to be disabling. Upon internal review, retinal edema and posterior vitreous detachment were considered to be medically significant. Additional information has been requested.
Phone call from patient with complaints following vaccination on 9/17/15 with Twinrix and Yellow Fever. Patient denies soreness, redness or swelling at site of yellow fever injection. She states she has a small bruise at the site of the Twinrix injection but denies redness or soreness. She stated the afternoon following these vaccines she began to have a headache and fatigue (which can be normal with either vaccine) and began running a fever which she states was 100-101 degrees Fahrenheit over the weekend. She states she also developed a rash on the bag of her left leg that spread to her left gluteus. She states it originally started as red bumps and has progressed to vesicles. She describes initial itching and burning then has turned into "searing pain" that feels like a "hot fire poker" in the gluteus and groin area. She also complains of a swollen lymph node in her left groin. She denies a rash on the front of the left leg or in any other area. She states she had 2 doses of varicella as an adult. Discussed with patient that I do not believe her symptoms are vaccine related and that her symptoms are consistent with shingles. I explained how shingles can occur if someone has had varicella vaccine or a history of chicken pox. I explained how stress or an immunocompromising condition may cause the virus which has laid dormant to be activated as shingles. I recommended she phone her PCP as soon as possible for possible anti-viral treatment which she can discuss with her PCP. I let her know that I will report her symptoms to VAERS but that I do not think her symptoms are vaccine related and that I would encourage her to continue her Twinrix series, yellow fever in the future if necessary and a shingles vaccine at age 60. I offered to call and discuss my thoughts and recommendations with her PCP and she declined.
Difficulty breathing Difficulty swallowing Drove POV to hospital - denied ambulance transport -mother denied ambulance
Pt vaccinated with FLU/Pneumoccoccal developed queasiness, N/V, diarrhea x 2-3hrs, chills, & dizziness x 1wk. Was kept in the infirmary at convelescent home for 3 days.
pt recv 1997 & pt exp malaise & flu-like sx for about 3 days;pt recovered;
experienced 8 hours of numbness around her lips after receiving her first dose of the Pfizer Covid vaccine on 19Jan2021.; This is a spontaneous report from a contactable consumer, the patient. A 53-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number was not reported), via an unspecified route of administration on 19Jan2021 as dose 1, single (at 53 year old) for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced 8 hours of numbness around her lips after receiving her first dose of the pfizer covid vaccine on 19Jan2021. The patient had second dose scheduled next week. The outcome of the event numbness lips was unknown.  Follow-up attempts completed. No further information expected.
Starting 3/17/21: left arm pain at injection site, resolved 3/19/21 Starting 3/17/21: mild fatigue which became severe on 3/18/21, had to take half day off work.  Completely resolved 3/19/21.